Manuel Chaves-Conde

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Eduardo Díaz‐Rubio, Josep Tabernero, Auxiliadora Gómez‐España et al. · Journal of Clinical Oncology · 2007 · 269 citations · Full text

Medicine, Oncology, Pharmacology +11

MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer

Sonia Molina‐Pinelo, Amancio Carnero, Fernando Rivera et al. · BMC Cancer · 2014 · 75 citations · Full text

Medicine, Bioinformatics, Oncology +17

Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study

Javier Sastre, Enrique Aranda, Bartomeu Massutí et al. · Critical Reviews in Oncology/Hematology · 2008 · 50 citations

Medicine, Geriatric Medicine, Oncology +11

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Barbara Burtness, Robert I. Haddad, José Dinis et al. · JAMA Oncology · 2019 · 43 citations · Full text

Medicine, Oncology, Radiation Oncology +12

MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer

Manuel Chaves-Conde, Verónica de Miguel Luken, Sandra Muñoz-Galván et al. · Oncotarget · 2015 · 29 citations · Full text

Medicine, Oncology, Radiation Oncology +13